Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Orgenesis ( (ORGS) ) is now available.
On August 8, 2025, Orgenesis Inc. announced the resignation of its Chief Financial Officer, Victor Miller, who left to pursue other opportunities. His departure was not due to any disagreements with the company’s management or board. Following this, on August 9, directors Yaron Adler and Adam Pelavin also resigned, and on August 18, director Santhosh Nagaraja stepped down. These resignations were similarly not due to any disputes with the company. Orgenesis expressed gratitude for their contributions.
Spark’s Take on ORGS Stock
According to Spark, TipRanks’ AI Analyst, ORGS is a Underperform.
Orgenesis faces substantial financial challenges, with negative revenue and cash flow issues indicating significant instability. Despite negative technical indicators, recent corporate governance improvements may provide a slight strategic advantage. However, these factors are overshadowed by the company’s overarching financial distress, resulting in a low overall stock score.
To see Spark’s full report on ORGS stock, click here.
More about Orgenesis
Average Trading Volume: 3,683
Technical Sentiment Signal: Sell
Current Market Cap: $113.7K
For a thorough assessment of ORGS stock, go to TipRanks’ Stock Analysis page.